Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RGR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RTCA | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MRPL35 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CTD-2528L19.4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PI4KB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NDUFS7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ZC3H4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CCDC3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF593 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |